How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/anti-ngf-ab.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Anti-NGF AB — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anti-NGF AB (Anti-NGF AB) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NGF antagonist. Area: Neurology.

phase 2 NGF antagonist NGF Neurology Biologic Live · refreshed every 30 min

Target snapshot

Anti-NGF AB (Anti-NGF AB) — Pfizer. Antagonist of nerve growth factor

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Anti-NGF AB TARGET	Anti-NGF AB	Pfizer	phase 2	NGF antagonist	NGF
NurOwn® (MSC-NTF cells)	NurOwn® (MSC-NTF cells)	Brainstorm-Cell Therapeutics	phase 3	Cell therapy	Neurotrophic factors (NGF, BDNF, GDNF)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (NGF antagonist class)

Pfizer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anti-NGF AB — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-ngf-ab. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing